Download presentation
Presentation is loading. Please wait.
Published bySatu Virtanen Modified over 5 years ago
1
Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline J Noble, MD, P.M. Ellis, MBBS, PhD, J.A. Mackay, MA, MSc, W.K. Evans, MD Journal of Thoracic Oncology Volume 1, Issue 9, Pages (November 2006) DOI: /S (15) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 Meta-analysis of Six-Month Survival for Weekly versus Three-Weekly Administration of Single-Agent Docetaxel. Abbreviations: CI = confidence interval, n = number of deaths, N = number of patients, RR = Relative Risk. Journal of Thoracic Oncology 2006 1, DOI: ( /S (15) ) Copyright © 2006 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.